G. S. Panayi

“Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte Activation

D. C. Dumonde, R. A. Wolstencroft, G. S. Panayi et al. · Nature · 1969 · 577 citations

Life Sciences, Cell Biology, Immunology +16

Therapeutic benefit of blocking interleukin‐6 activity with an anti–interleukin‐6 receptor monoclonal antibody in rheumatoid arthritis: A randomized, double‐blind, placebo‐controlled, dose‐escalation trial

Ernest Choy, David Isenberg, Toby Garrood et al. · Arthritis & Rheumatism · 2002 · 535 citations

Life Sciences, Immunology, Pharmacotherapy +15

Genetic polymorphism of IL-12 p40 gene in immune-mediated disease

MA Hall, Edwina McGlinn, Gillian Coakley et al. · Genes and Immunity · 2000 · 153 citations

Life Sciences, Genetics, Immunology +16

Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis.

Bhaskar DasGupta, Michael Corkill, B. W. Kirkham et al. · PubMed · 1992 · 134 citations

Life Sciences, Immunology, Internal Medicine +17

An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica

Bhaskar DasGupta, A. L. Dolan, G. S. Panayi et al. · Lara D. Veeken · 1998 · 112 citations

Pharmacy, Pharmacotherapy, Dosage Form Design +12